Table 1.
Features | Platelet components with abnormalities | Disease |
---|---|---|
Abnormalities of the platelet receptors for adhesive proteins | GPIb-IX-V complex | Bernard-Soullier syndrome, platelet-type vWD |
GPIIb-IIIa (αIIbβ3) | Glanzmann thrombasthenia | |
GPIa-IIa (α2β1) | ||
GPVI | ||
Abnormalities of the platelet receptors for soluble agonists | P2Y12 receptor | P2Y12 receptor deficiency |
Thromboxane A2 receptor | Thromboxane A2 receptor deficiency | |
α2-adrenergic receptor | ||
Abnormalities of the platelet granules | δ-granules | Nonsyndromic δ-storage pool deficiency, Hermansky-Pudlak syndrome, Chediak-Higashi syndrome, MPR4 deficiency, thrombocytopenia with absent radii syndrome, Wiskott-Aldrich syndrome |
α-granules | Gray platelet syndrome, Quebec platelet disorder, 11q terminal deletion disorder, White platelet syndrome, Medich platelet disorder, X-linked macrothrombocytopenia with thalassemia, arthrogryposis renal dysfunction, and cholestasis syndrome | |
α- and δ-granules | α, δ-storage pool deficiency | |
Defects of signal transduction | Arachinodate/thromboxane A2 pathway | |
GTP binding proteins | ||
Phospholipase C activation | ||
Transcription factors | ||
GPVI/FcRc signaling | ||
Leukocyte adhesion deficiency-III | ||
Abnormalities of membrane phospholipids | Membrane phospholipids | Scott syndrome, Stormorken syndrome |
Miscellaneous abnormalities of platelet function | Primary secretion defects | |
Others | Osteogenesis imperfecta, Ehlers-Danlos syndrome, Marfan syndrome, hexokinase deficiency, glucose-6-phosphate deficiency |
Abbreviations: GP, glycoprotein; FcRc, Fc receptor; vWD, von Willebrand disease.